Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 26;14(13):4529.
doi: 10.3390/jcm14134529.

Assessment of Kynurenine Pathway Enzyme Activity in Ocular Diseases: Associations with Cataract, Diabetes, Glaucoma, and Pseudoexfoliation Syndrome

Arturs Zemitis  1   2 , Juris Vanags  1   2 , Kristaps Klavins  3 , Guna Laganovska  1   2
Affiliations

Assessment of Kynurenine Pathway Enzyme Activity in Ocular Diseases: Associations with Cataract, Diabetes, Glaucoma, and Pseudoexfoliation Syndrome

Arturs Zemitis et al. J Clin Med. .

Abstract

Purpose: To investigate the role of the kynurenine pathway (KP) in ocular diseases by evaluating the activity of key enzymes-kynurenine aminotransferase (KAT) and kynurenine monooxygenase (KMO)-and the 3-hydroxykynurenine to kynurenic acid (3-HK/KYNA) ratio in relation to cataract severity, diabetes, glaucoma, and pseudoexfoliation syndrome (PEXS). Methods: Tryptophan metabolite levels were measured in patients undergoing cataract surgery and stratified by SPONCS grading and comorbid conditions. KAT and KMO activities were estimated using metabolite ratios (KYNA/KYN and 3-HK/KYN, respectively). Statistical analyses included Kruskal-Wallis tests with post hoc comparisons and Mann-Whitney U tests. Results: KAT activity declined significantly with increasing SPONCS grade (p = 0.014), suggesting a progressive loss of KYNA production and antioxidative capacity in advanced cataracts. Diabetic patients exhibited higher KMO activity (p = 0.039) and elevated 3-HK/KYNA ratios (p = 0.013), indicating a metabolic shift toward oxidative stress and neurotoxicity. Similarly, glaucoma patients had significantly increased KMO activity (p = 0.032), consistent with enhanced 3-HK-mediated retinal ganglion cell damage. In contrast, PEXS showed no significant alterations in KP markers. Conclusions: The kynurenine pathway is differentially modulated in ocular diseases. A decline in KAT activity correlates with cataract severity, while upregulation of KMO is prominent in diabetes and glaucoma, revealing disease-specific metabolic dysregulation. Targeting KMO to reduce toxic metabolite accumulation or enhancing KYNA synthesis may offer novel therapeutic avenues. These findings also support the potential of KP metabolites as biomarkers for disease monitoring and progression.

Keywords: 3-Hydroxykynurenine; cataract; diabetes; glaucoma; kynurenic acid; kynurenine aminotransferase; kynurenine monooxygenase; kynurenine pathway; ocular metabolism; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflicts of interest.

References

    1. Fiedorowicz M., Choragiewicz T., Thaler S., Schuettauf F., Nowakowska D., Wojtunik K., Reibaldi M., Avitabile T., Kocki T., Turski W.A., et al. Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes. Front. Physiol. 2019;10:1254. doi: 10.3389/fphys.2019.01254. - DOI - PMC - PubMed
    1. Hazrati E., Eftekhar S.P., Mosaed R., Dini S.S., Namazi M. Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions. Mol. Pain. 2024;20:17448069241275097. doi: 10.1177/17448069241275097. - DOI - PMC - PubMed
    1. Linetsky M., Raghavan C.T., Johar K., Fan X., Monnier V.M., Vasavada A.R., Nagaraj R.H. UVA light-excited kynurenines oxidize ascorbate and modify lens proteins through the formation of advanced glycation end products: Implications for human lens aging and cataract formation. J. Biol. Chem. 2014;289:17111–17123. doi: 10.1074/jbc.M114.554410. - DOI - PMC - PubMed
    1. Aquilina J.A., Carver J.A., Truscott R.J. Oxidation products of 3-hydroxykynurenine bind to lens proteins: Relevance for nuclear cataract. Exp. Eye Res. 1997;64:727–735. doi: 10.1006/exer.1996.0258. - DOI - PubMed
    1. Goldstein L.E., Leopold M.C., Huang X., Atwood C.S., Saunders A.J., Hartshorn M., Lim J.T., Faget K.Y., Muffat J.A., Scarpa R.C., et al. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry. 2000;39:7266–7275. doi: 10.1021/bi992997s. - DOI - PubMed

LinkOut - more resources